SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Patrizia LoPresti, Glatiramer Acetate Guards Against Rapid Memory Decline During Relapsing-Remitting Experimental Autoimmune Encephalomyelitis, Neurochemical Research, 2015, 40, 3, 473

    CrossRef

  2. 2
    David C. Landy, Eric M. Hecht, Benefit of Additional Screening for Progressive Multifocal Leukoencephalopathy in Patients With Multiple Sclerosis Taking Natalizumab, Clinical Neuropharmacology, 2014, 37, 2, 45

    CrossRef

  3. 3
    Uwe K. Zettl, Thomas Henze, Ute Essner, Peter Flachenecker, Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I), The European Journal of Health Economics, 2014, 15, 9, 953

    CrossRef

  4. 4
    Janet GM Markle, Daniel N Frank, Khosrow Adeli, Martin von Bergen, Jayne S Danska, Microbiome manipulation modifies sex-specific risk for autoimmunity, Gut Microbes, 2014, 5, 4, 485

    CrossRef

  5. 5
    Christine G. Kohn, Craig I. Coleman, C. Michael White, Matthew F. Sidovar, Diana M. Sobieraj, Mobility, walking and physical activity in persons with multiple sclerosis, Current Medical Research and Opinion, 2014, 30, 9, 1857

    CrossRef

  6. 6
    Ranjan Dutta, Bruce D. Trapp, Relapsing and progressive forms of multiple sclerosis, Current Opinion in Neurology, 2014, 27, 3, 271

    CrossRef

  7. 7
    Thomas F. Scott, Christopher T. Hackett, Matthew R. Quigley, Carol J. Schramke, Relapsing multiple sclerosis patients treated with disease modifying therapy exhibit highly variable disease progression: A predictive model, Clinical Neurology and Neurosurgery, 2014, 127, 86

    CrossRef

  8. 8
    J.G. Markle, E.N. Fish, SeXX matters in immunity, Trends in Immunology, 2014, 35, 3, 97

    CrossRef

  9. 9
    S. Du, N. Itoh, S. Askarinam, H. Hill, A. P. Arnold, R. R. Voskuhl, XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis, Proceedings of the National Academy of Sciences, 2014, 111, 7, 2806

    CrossRef

  10. 10
    Gerson Criste, Bruce Trapp, Ranjan Dutta, Multiple Sclerosis and Related Disorders, 2014,

    CrossRef

  11. 11
    Amanda L. Hernandez, Kevin C. O’Connor, David A. Hafler, The Autoimmune Diseases, 2014,

    CrossRef

  12. 12
    Antonio Cerasa, Maria Salsone, Maurizio Morelli, Pierfrancesco Pugliese, Gennarina Arabia, Cecilia M. Gioia, Fabiana Novellino, Aldo Quattrone, Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias, Parkinsonism & Related Disorders, 2013, 19, 10, 883

    CrossRef

  13. 13
    Lutz Achtnichts, Oded Gonen, Daniel J. Rigotti, James S. Babb, Yvonne Naegelin, Iris-Katharina Penner, Kerstin Bendfeldt, Jochen Hirsch, Michael Amann, Ludwig Kappos, Achim Gass, Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration, European Journal of Radiology, 2013, 82, 12, e848

    CrossRef

  14. 14
    Ranjan Dutta, Anthony M. Chomyk, Ansi Chang, Michael V. Ribaudo, Sadie A. Deckard, Mary K. Doud, Dale D. Edberg, Brian Bai, Michael Li, Sergio E. Baranzini, Robert J. Fox, Susan M. Staugaitis, Wendy B. Macklin, Bruce D. Trapp, Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors, Annals of Neurology, 2013, 73, 5
  15. 15
    Francisco P. Gomez, Andrew J. Steelman, Colin R. Young, C. Jane Welsh, Hormone and immune system interactions in demyelinating disease, Hormones and Behavior, 2013, 63, 2, 315

    CrossRef

  16. 16
    J. G. M. Markle, D. N. Frank, S. Mortin-Toth, C. E. Robertson, L. M. Feazel, U. Rolle-Kampczyk, M. von Bergen, K. D. McCoy, A. J. Macpherson, J. S. Danska, Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity, Science, 2013, 339, 6123, 1084

    CrossRef

  17. 17
    Maria K. Houtchens, Samia J. Khoury, Women and Health, 2013,

    CrossRef

  18. 18
    Sue Rutherford Siegel, Jason Mackenzie, George Chaplin, Nina G. Jablonski, Lyn Griffiths, Circulating microRNAs involved in multiple sclerosis, Molecular Biology Reports, 2012, 39, 5, 6219

    CrossRef

  19. 19
    Manav Malhotra, Pankaj Ghai, Balasubramanian Narasimhan, Aakash Deep, Dalfampridine: Review on its recent development for symptomatic improvement in patients with multiple sclerosis, Arabian Journal of Chemistry, 2012,

    CrossRef

  20. 20
    Ranjan Dutta, Bruce D. Trapp, Gene expression profiling in multiple sclerosis brain, Neurobiology of Disease, 2012, 45, 1, 108

    CrossRef

  21. 21
    Babak Jalilian, Halldór Einarsson, Thomas Vorup-Jensen, Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System?, International Journal of Molecular Sciences, 2012, 13, 12, 14579

    CrossRef

  22. 22
    M. H. Harirchian, A. H. Tekieh, A. Modabbernia, V. Aghamollaii, A. Tafakhori, M. Ghaffarpour, M. A. Sahraian, M. Naji, M. Yazdanbakhsh, Serum and CSF PDGF-AA and FGF-2 in relapsing-remitting multiple sclerosis: a case–control study, European Journal of Neurology, 2012, 19, 2
  23. 23
    C. Comi, T. Fleetwood, U. Dianzani, The role of T cell apoptosis in nervous system autoimmunity, Autoimmunity Reviews, 2012, 12, 2, 150

    CrossRef

  24. 24
    Cherilyn R. Strader, Cedric J. Pearce, Nicholas H. Oberlies, Fingolimod (FTY720): A Recently Approved Multiple Sclerosis Drug Based on a Fungal Secondary Metabolite, Journal of Natural Products, 2011, 74, 4, 900

    CrossRef

  25. 25
    P.E. Bermejo Velasco, M.R. Blasco Quílez, A.J. Sánchez López, A. García Merino, Manifestaciones clínicas, historia natural, pronóstico y complicaciones de la esclerosis múltiple, Medicine - Programa de Formación Médica Continuada Acreditado, 2011, 10, 75, 5079

    CrossRef

  26. 26
    Ranjan Dutta, Bruce D. Trapp, Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis, Progress in Neurobiology, 2011, 93, 1, 1

    CrossRef

  27. 27
    Scott D. Newsome, Joseph I. Wang, Jonathan Y. Kang, Peter A. Calabresi, Kathleen M. Zackowski, Quantitative measures detect sensory and motor impairments in multiple sclerosis, Journal of the Neurological Sciences, 2011, 305, 1-2, 103

    CrossRef

  28. 28
    Michelle Stern, Lyssa Sorkin, Kelly Milton, Kevin Sperber, Aging with Multiple Sclerosis, Physical Medicine and Rehabilitation Clinics of North America, 2010, 21, 2, 403

    CrossRef

  29. 29
    Ivan I. Kirov, Songtao Liu, Roman Fleysher, Lazar Fleysher, James S. Babb, Joseph Herbert, Oded Gonen, Brain Metabolite Proton T2 Mapping at 3.0 T in Relapsing-Remitting Multiple Sclerosis1, Radiology, 2010, 254, 3, 858

    CrossRef

  30. 30
    B. Anderseck, J. Kesselring, Die Alltagsbewältigung verbessern, ProCare, 2010, 15, 5, 16

    CrossRef

  31. 31
    Rosa María Licón Luna, Dezsö Körmendy, Monika C. Brunner-Weinzierl, Female-biased incidence of experimental autoimmune encephalomyelitis reflects sexually dimorphic expression of surface CTLA-4 (CD152) on T lymphocytes, Gender Medicine, 2010, 7, 4, 296

    CrossRef

  32. 32
    Zeenat F Zaidi, Gender Differences in Human Brain: A Review, The Open Anatomy Journal, 2010, 2, 37

    CrossRef

  33. 33
    Céline Jobin, Catherine Larochelle, Hélène Parpal, Patricia K Coyle, Pierre Duquette, Gender issues in multiple sclerosis: an update, Women's Health, 2010, 6, 6, 797

    CrossRef

  34. 34
    Rhonda Voskuhl, MULTIPLE SCLEROSIS 3, 2010,

    CrossRef

  35. 35
    Franz Fazekas, Christian Enzinger, Mirja Wallner-Blazek, Stefan Ropele, Aga Pluta-Fuerst, Siegrid Fuchs, Gender differences in MRI studies on multiple sclerosis, Journal of the Neurological Sciences, 2009, 286, 1-2, 28

    CrossRef

  36. 36
    Ben W. Thrower, Relapse Management in Multiple Sclerosis, The Neurologist, 2009, 15, 1, 1

    CrossRef

  37. 37
    Marcia Finlayson, Jennifer Dahl Garcia, Katharine L. Preissner, Retracted: Development of an education programme for caregivers of people aging with multiple sclerosis, Occupational Therapy International, 2009, 16, 2
  38. 38
    Stefan M. Gold, Rhonda R. Voskuhl, Neurotherapy: Progress in Restorative Neuroscience and Neurology, 2009,

    CrossRef

  39. 39
    R. Voskuhl, Hormones, Brain and Behavior, 2009,

    CrossRef

  40. 40
    Nuhad Abou Zeid, M Tariq Bhatti, Acute Inflammatory Demyelinating Optic Neuritis, The Neurologist, 2008, 14, 4, 207

    CrossRef

  41. 41
    Marcia Finlayson, Jennifer Dahl Garcia, Katharine Preissner, Development of an educational programme for caregivers of people aging with multiple sclerosis, Occupational Therapy International, 2008, 15, 1
  42. 42
    M. Pugliatti, T. Riise, M. W. Nortvedt, G. Carpentras, M. A. Sotgiu, S. Sotgiu, G. Rosati, Self-perceived physical functioning and health status among fully ambulatory multiple sclerosis patients, Journal of Neurology, 2008, 255, 2, 157

    CrossRef

  43. 43
    Sasitorn Siritho, Naraporn Prayoonwiwat, A Retrospective Study of Multiple Sclerosis in Siriraj Hospital, Bankok, Thailand, The Canadian Journal of Neurological Sciences, 2007, 34, 01, 99

    CrossRef

  44. 44
    Lotti Tajouri, Francesca Fernandez, Sophie Tajouri, Geraldine Detriche, Attila Szvetko, Natalie Colson, Peter Csurhes, Michael P. Pender, Lyn R. Griffiths, Allelic variation investigation of the estrogen receptor within an Australian multiple sclerosis population, Journal of the Neurological Sciences, 2007, 252, 1, 9

    CrossRef

  45. 45
    A. H. Maghzi, M. Etemadifar, M. Saadatnia, Clinical and demographical characteristics of primary progressive multiple sclerosis in Isfahan, Iran, European Journal of Neurology, 2007, 14, 4
  46. 46
    Molly E. Gilbert, Robert C. Sergott, New directions in optic neuritis and multiple sclerosis, Current Neurology and Neuroscience Reports, 2007, 7, 3, 259

    CrossRef

  47. 47
    Philip L. De Jager, David A. Hafler, New Therapeutic Approaches for Multiple Sclerosis, Annual Review of Medicine, 2007, 58, 1, 417

    CrossRef

  48. 48
    Adi Vaknin-Dembinsky, Howard L. Weiner, Relationship of immunologic abnormalities and disease stage in multiple sclerosis: Implications for therapy, Journal of the Neurological Sciences, 2007, 259, 1-2, 90

    CrossRef

  49. 49
    D.J. Rigotti, M. Inglese, O. Gonen, Whole-Brain N-Acetylaspartate as a Surrogate Marker of Neuronal Damage in Diffuse Neurologic Disorders, American Journal of Neuroradiology, 2007, 28, 10, 1843

    CrossRef

  50. 50
    Getaw Worku Hassen, Jason Feliberti, Leo Kesner, Alfred Stracher, Foroozan Mokhtarian, A novel calpain inhibitor for the treatment of acute experimental autoimmune encephalomyelitis, Journal of Neuroimmunology, 2006, 180, 1-2, 135

    CrossRef

  51. 51
    S Schmidt, M A Pericak-Vance, S Sawcer, L F Barcellos, J Hart, J Sims, A M Prokop, J van der Walt, C DeLoa, R R Lincoln, J R Oksenberg, A Compston, S L Hauser, J L Haines, S G Gregory, Allelic association of sequence variants in the herpes virus entry mediator-B gene (PVRL2) with the severity of multiple sclerosis, Genes and Immunity, 2006, 7, 5, 384

    CrossRef

  52. 52
    O. Deryck, P. Ketelaer, B. Dubois, Clinical characteristics and long term prognosis in early onset multiple sclerosis, Journal of Neurology, 2006, 253, 6, 720

    CrossRef

  53. 53
    S. Cantalloube, I. Monteil, D. Lamotte, L. Mailhan, P. Thoumie, Évaluation préliminaire des effets de la rééducation sur les paramètres de force, d'équilibre et de marche dans la sclérose en plaques, Annales de Réadaptation et de Médecine Physique, 2006, 49, 4, 143

    CrossRef

  54. 54
    G. Coppola, R. Lanzillo, C. Florio, G. Orefice, P. Vivo, S. Ascione, V. Schiavone, A. Pagano, G. Vacca, G. De Michele, V. Brescia Morra, Long-term clinical experience with weekly interferon beta-1a in relapsing multiple sclerosis, European Journal of Neurology, 2006, 13, 9
  55. 55
    Edward J. Fox, Management of worsening multiple sclerosis with mitoxantrone: A review, Clinical Therapeutics, 2006, 28, 4, 461

    CrossRef

  56. 56
    Giancarlo Comi, Gianvito Martino, MS treatment: New perspectives, Clinical Neurology and Neurosurgery, 2006, 108, 3, 339

    CrossRef

  57. 57
    Roberto Bergamaschi, Prognosis of multiple sclerosis: clinical factors predicting the late evolution for an early treatment decision, Expert Review of Neurotherapeutics, 2006, 6, 3, 357

    CrossRef

  58. 58
    Marcia L. Finlayson, Elizabeth W. Peterson, Chi C. Cho, Risk Factors for Falling Among People Aged 45 to 90 Years With Multiple Sclerosis, Archives of Physical Medicine and Rehabilitation, 2006, 87, 9, 1274

    CrossRef

  59. 59
    Stefan Cano, Jeremy Hobart, Neurological Rehabilitation of Multiple Sclerosis, 2006,

    CrossRef

  60. 60
    Michelle Stern, Aging with multiple sclerosis, Physical Medicine and Rehabilitation Clinics of North America, 2005, 16, 1, 219

    CrossRef

  61. 61
    L. Tajouri, A.S. Mellick, A. Tourtellotte, R.M. Nagra, L.R. Griffiths, An examination of MS candidate genes identified as differentially regulated in multiple sclerosis plaque tissue, using absolute and comparative real-time Q-PCR analysis, Brain Research Protocols, 2005, 15, 2, 79

    CrossRef

  62. 62
    Mar Tintoré, Alex Rovira, Jordi Rio, Carlos Nos, Elisensa Grivé, Neus Téllez, Raul Pelayo, Manuel Comabella, Xavier Montalban, Is optic neuritis more benign than other first attacks in multiple sclerosis?, Annals of Neurology, 2005, 57, 2
  63. 63
    George D. Fulk, Locomotor Training and Virtual Reality-based Balance Training for an Individual with Multiple Sclerosis, Journal of Neurologic Physical Therapy, 2005, 29, 1, 34

    CrossRef

  64. 64
    Vincenza Sofo, Francesca Maria Salmeri, Paolo Di Bella, Edoardo Sessa, Giangaetano D'Aleo, Giuseppe Trimarchi, Placido Bramanti, Short Communication:Impairment of Membrane Markers on Peripheral Blood Mononuclear Cells and Imbalance of Cytokine Secretion in the Pathogenesis of Multiple Sclerosis Active Phases, Journal of Interferon & Cytokine Research, 2005, 25, 11, 661

    CrossRef

  65. 65
    J.-C. Ouallet, B. Brochet, Aspects cliniques, physiopathologiques, et thérapeutiques de la sclérose en plaques, EMC - Neurologie, 2004, 1, 4, 1

    CrossRef

  66. 66
    J.-C. Ouallet, B. Brochet, Aspects cliniques, physiopathologiques, et thérapeutiques de la sclérose en plaques, EMC - Neurologie, 2004, 1, 4, 415

    CrossRef

  67. 67
    Terry DiLorenzo, June Halper, Mary Ann Picone, Comparison of Older and Younger Individuals With Multiple Sclerosis: A Preliminary Investigation., Rehabilitation Psychology, 2004, 49, 2, 123

    CrossRef

  68. 68
    Lotti Tajouri, Virginie Martin, Micky Ovcaric, Rob P Curtain, Rod A Lea, Peter Csurhes, Michael P Pender, Lyn R Griffiths, Investigation of an inducible nitric oxide synthase gene (NOS2A) polymorphism in a multiple sclerosis population, Brain Research Bulletin, 2004, 64, 1, 9

    CrossRef

  69. 69
    David A. Hafler, Multiple sclerosis, Journal of Clinical Investigation, 2004, 113, 6, 788

    CrossRef

  70. 70
    David A. Hafler, Multiple sclerosis, Journal of Clinical Investigation, 2004, 113, 6, 788

    CrossRef

  71. 71
    I. Dujmović, Š Mesaroš, T. Pekmezović, Z. Lević, J. Drulović, Primary progressive multiple sclerosis: clinical and paraclinical characteristics with application of the new diagnostic criteria, European Journal of Neurology, 2004, 11, 7
  72. 72
    A. Achiron, G. Lavie, I. Kishner, Y. Stern, I. Sarova-Pinhas, T. Ben-Aharon, Y. Barak, H. Raz, M. Lavie, T. Barliya, M. Faibel, I.R. Cohen, M. Mandel, T cell vaccination in multiple sclerosis relapsing–remitting nonresponders patients, Clinical Immunology, 2004, 113, 2, 155

    CrossRef

  73. 73
    M. Bilinska, I. Frydecka, R. Podemski, E. Gruszka, Fas expression on T cells and sFas in relapsing-remitting multiple sclerosis, Acta Neurologica Scandinavica, 2003, 107, 6
  74. 74
    A.J. Thompson, S. Hesse, Neurological Disorders, 2003,

    CrossRef

  75. 75
    Roland Martin, Reinhard Hohlfeld, H.F. McFarland, Neurological Disorders, 2003,

    CrossRef

  76. 76
    Rhonda R. Voskuhl, Gender issues and multiple sclerosis, Current Neurology and Neuroscience Reports, 2002, 2, 3, 277

    CrossRef

  77. 77
    Richard K. Burt, Shimon Slavin, William H. Burns, Alberto M. Marmont, Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: Getting closer to a cure?, International Journal of Hematology, 2002, 76, S1, 226

    CrossRef

  78. 78
    G.V McDonnell, S.A Hawkins, Primary progressive multiple sclerosis: increasing clarity but many unanswered questions, Journal of the Neurological Sciences, 2002, 199, 1-2, 1

    CrossRef

  79. 79
    Oded Gonen, David M. Moriarty, Belinda S. Y. Li, James S. Babb, Juan He, John Listerud, Dina Jacobs, Clyde E. Markowitz, Robert I. Grossman, Relapsing-remitting Multiple Sclerosis and Whole-BrainN-Acetylaspartate Measurement: Evidence for Different Clinical Cohorts—Initial Observations1, Radiology, 2002, 225, 1, 261

    CrossRef

  80. 80
    Giancarlo Comi, Massimo Filippi, Jerry S. Wolinsky, European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis , Annals of Neurology, 2001, 49, 3
  81. 81
    Florian Von Raison, Interferon beta-1a treatment reduces incidence of multiple sclerosis when initiated during first demyelinating event, Evidence-based Healthcare, 2001, 5, 3, 91

    CrossRef

  82. 82
    Clara Ballerini, Daniela Campani, Giovanni Rombolà, Bruno Gran, Benedetta Nacmias, Maria Pia Amato, Gianfranco Siracusa, Letizia Bartolozzi, Sandro Sorbi, Luca Massacesi, Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis, Neuroscience Letters, 2000, 296, 2-3, 174

    CrossRef

  83. 83
    Richard M Ransohoff, Kevin B Bacon, Chemokine receptor antagonism as a new therapy for multiple sclerosis, Expert Opinion on Investigational Drugs, 2000, 9, 5, 1079

    CrossRef

  84. 84
    Robert S. Rust, Multiple sclerosis, acute disseminated encephalomyelitis, and related conditions, Seminars in Pediatric Neurology, 2000, 7, 2, 66

    CrossRef

  85. 85
    Anne Graham, Joseph Reser, Carl Scuderi, Stephen Zubrick, Meg Smith, Bruce Turley, Suicide: An Australian Psychological Society Discussion Paper, Australian Psychologist, 2000, 35, 1
  86. 86
    Michael J. Olek, Samia J. Khoury, Women and Health, 2000,

    CrossRef

  87. 87
    G.V. McDonnell, H. Mawhinney, C.A. Graham, S.A. Hawkins, D. Middleton, A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis, Journal of the Neurological Sciences, 1999, 165, 1, 77

    CrossRef

  88. 88
    Carolyn E Schwartz, Rabbi Meir Sendor, Helping others helps oneself: response shift effects in peer support, Social Science & Medicine, 1999, 48, 11, 1563

    CrossRef

  89. 89
    Antonella Giannantoni, Giorgio Scivoletto, Savino M. Di Stasi, Maria Grazia Grasso, Enrico Finazzi Agrò, Giuseppe Collura, Giuseppe Vespasiani, Lower urinary tract dysfunction and disability status in patients with multiple sclerosis, Archives of Physical Medicine and Rehabilitation, 1999, 80, 4, 437

    CrossRef

  90. 90
    Richard A Rudick, Andrew Goodman, Robert M Herndon, Hillel S Panitch, Selecting relapsing remitting multiple sclerosis patients for treatment: the case for early treatment, Journal of Neuroimmunology, 1999, 98, 1, 22

    CrossRef

  91. 91
    P Gallien, S Robineau, Sensory-motor and genito-sphincter dysfunctions in multiple sclerosis, Biomedicine & Pharmacotherapy, 1999, 53, 8, 380

    CrossRef

  92. 92
    Suzanne Palmer, William G. Bradley, Dar-Yeong Chen, Sangita Patel, Subcallosal Striations: Early Findings of Multiple Sclerosis on Sagittal, Thin-Section, Fast FLAIR MR Images, Radiology, 1999, 210, 1, 149

    CrossRef

  93. 93
    G.P. Rice, J. Oger, P. Duquette, G.S. Francis, M. Bélanger, S. Laplante, J.F. Grenier, Treatment with Interferon Beta-1b Improves Quality of Life in Multiple Sclerosis, The Canadian Journal of Neurological Sciences, 1999, 26, 04, 276

    CrossRef

  94. 94
    Alastair J.J. Wood, Richard A. Rudick, Jeffrey A. Cohen, Bianca Weinstock-Guttman, Revere P. Kinkel, Richard M. Ransohoff, Management of Multiple Sclerosis, New England Journal of Medicine, 1997, 337, 22, 1604

    CrossRef

  95. 95
    Debra L. Braverman, Elisabeth A. Lachmann, Richard Tunkel, Willibald Nagler, Multiple sclerosis presenting as a spinal cord tumor, Archives of Physical Medicine and Rehabilitation, 1997, 78, 11, 1274

    CrossRef

  96. 96
    J. A. Freeman, D. W. Langdon, J. C. Hobart, A. J. Thompson, The impact of inpatient rehabilitation on progressive multiple sclerosis, Annals of Neurology, 1997, 42, 2
  97. 97
    John N. Whitaker, Galen W. Mitchell, A possible role for altered myelin basic protein in multiple sclerosis, Annals of Neurology, 1996, 40, 1
  98. 98
    Basil Sharrack, Richard A.C. Hughes, Clinical scales for multiple sclerosis, Journal of the Neurological Sciences, 1996, 135, 1, 1

    CrossRef

  99. 99
    John Hackett, Priscilla Swanson, David Leahy, Eve L. Anderson, Shigeru Sato, Raymond P. Roos, Richard Decker, Sushil G. Devare, Search for retrovirus in patients with multiple sclerosis, Annals of Neurology, 1996, 40, 5